Infectious Diseases Prof working across continents & disciplines.
#HBV #hepatitis research
@Crick.ac.uk @UCL.ac.uk @uclh.bsky.social
https://www.crick.ac.uk/research/labs/philippa-matthews
🦠🧬🧪🩺🌍🇿🇦🇰🇪🇺🇬🇪🇺
#globalhealth #NHS #IDSky #MedSky #HepSky #European
Philippa Matthews
Loading...
Going green at The Francis Crick Institute. Small steps by each person and group add up to the bigger picture of progress towards #CarbonNeutral. This is tough in #science #research which is very heavy on consumables, materials, energy, travel… but we’re making changes. 💚🧪🌱
@crick.ac.uk
Crimes against humanity.
🧪 #MedSky
From targets to real world impact: a review of models of care for #HBV & #HCV in #Europe. We have so many tools, but need to use them better. Fantastic team effort to review the evidence (& identify gaps!)
@thelancet.com @who.int @crick.ac.uk #MedSky #LiverSky 🧪
www.thelancet.com/journals/lan...
A changing #HIV #treatment landscape:
What does #lenacapavir mean for people living with #HBV?
@lancetgastrohep.bsky.social
@crick.ac.uk @ahri-news.bsky.social @whowpro.bsky.social
#IDSky #LiverSky #MedSky #Hepatitis #NoHep
🧪💊🦠🇿🇦
www.thelancet.com/journals/lan...
Great infographic to support this article about viral #hepatitis produced by @isglobal.bsky.social as part of a series by @thelancet.com - which also considers other threats including #alcohol and #MASLD.
Well done to all contributors for highlighting the neglected world of #LiverHealth.
Here is a link to our poster presenting use of #PrEP for #HIV #prevention & #HBV #treatment, presented at #BHIVABASHH26.
Aiming for holistic, equitable care.
#MedSky #HepSky #IDSky #NoHep #PublicHealth
🧪
@cnwl.nhs.uk @uclh.bsky.social @uclhresearch.bsky.social
doi.org/10.6084/m9.f...
Our work on #MASLD & #HBV is a research highlight @crick.ac.uk 🎖️
If we cut through the acronym forest, what we're asking is how we can do better at diagnosing & understanding overlapping causes of #liver disease, to help provide better patient care 🩺.
More to follow soon 👀
#LiverSky #MedSky 🧪
“For people with chronic #disease, #displacement is not just a social crisis, it is a medical #emergency in slow motion.”
Applies both to #infection and #NCDs.
Continuity of care is not a luxury, it is essential.
Presentation from #Iraq for #RCPGlobal @rcphysicians.bsky.social meeting.
#MedSky 🧪
South Africa has world's largest HIV epidemic & helped prove lenacapavir works, yet Trump admin refuses funding & Gilead controls supply. Millions left without access to drug that could prevent 52k infections yearly
#HIV
#SouthAfrica
#AccessToMedicine
A year after global #HIV funding was upended, CHAI finds:
⬇️ 42% fewer people started oral HIV prevention in 10 countries
⬇️ 5.8M fewer HIV tests run in 8 countries
⬇️ 39K fewer adults started on treatment in 8 countries
⬇️ 26K fewer children on treatment in 9 countries
Details here: ow.ly/J2ig50Z8Rzt
Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain public health threats in
the WHO European region, where an estimated 29 million people live with chronic infection
and viral hepatitis-relate...
An exciting shift is underway in progress towards tackling HIV as a global public
health threat, as we enter a new era of nucleotide and nucleoside reverse transcriptase
inhibitor (NRTI)-free dual reg...
BRATISLAVA, June 9 (IPS) - As South Africa officially launches the rollout of a groundbreaking HIV prevention drug, civic groups in the country have slammed the plan, saying it will not reach anywhere near enough people.
This is a poster to describe the population of people living with chronic Hepatitis B (PLHBV) who are accessing HIV pre-exposure prophylaxis (also known as PrEP) from Mortimer Market (London, UK), where our service provides care for people living with chronic (long-term) viral infections.These individuals may benefit from Tenofovir-based combination antiretroviral therapy for both HBV treatment HIV PrEP, and the benefits of PrEP are yet to be fully realised in this population.This information is helpful in shaping future ideas on how to provide wider/holistic care for PLWHB
Diagnosing and defining #MASLD in people living with #hepatitisB. Our #review addresses this important question - but answers are still uncertain. More #research is needed to improve technology, understand caveats, & reduce #health inequity.
#MedSky #LiverSky #HBV 🧪
www.nature.com/articles/s43...
Data on use of #PrEP for #HIV prevention & #HBV treatment from #London …this makes perfect biological & economic sense & allows us to deliver more holistic services; no adverse events.
Congrats Maeve Barlow on commendation! 🧪
@uclh.bsky.social @cnwl.nhs.uk
#BHIVABASHH26 #IDSky
@bhiva.bsky.social
Martyn et al collate evidence for identifying metabolic dysfunction associated liver disease (MASLD) in people living with chronic hepatitis B virus infection. They highlight inconsistencies and gaps,...
